ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $45,283,000 | -6.4% | 45,700,000 | 0.0% | 1.57% | -17.6% |
| Q4 2017 | $48,392,000 | -0.2% | 45,700,000 | 0.0% | 1.90% | -12.8% |
| Q3 2017 | $48,504,000 | +8.0% | 45,700,000 | +8.3% | 2.18% | -8.7% |
| Q2 2017 | $44,891,000 | -25.5% | 42,200,000 | -32.5% | 2.39% | +3.1% |
| Q1 2017 | $60,243,000 | +78.2% | 62,500,000 | +88.3% | 2.32% | +67.0% |
| Q4 2016 | $33,802,000 | – | 33,186,000 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |